Dupilumab in CRSwNP: Responder Analysis Using Clinically Meaningful Efficacy Outcome Thresholds. Chuang CC, Guillemin I, Bachert C, Lee SE, et al. Laryngoscope 2022;132:259-264.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chuang CC, Guillemin I, Bachert C, Lee SE, et al. Dupilumab in CRSwNP: Responder Analysis Using Clinically Meaningful Efficacy Outcome Thresholds. Laryngoscope 2022;132:259-264.
PMID: 34817082